Sona Nanotech Inc.
- Medical device or technology
- Biotech or pharma, therapeutic R&D
Near-clinical stage novel immunotherapy device company using proprietary nanotechnology for 'Targeted Hyperthermia Therapy' for solid cancer tumors. Therapy selectively kills cancer cells and in so doing causes the release of neo-antigens, engaging the immune system and causing significantly higher response rates to immunotherapy drugs in preclinical models for melanoma, colorectal cancer and triple negative breast cancer which have shown 100% response rates. Published in Frontiers in Immunology in January with 5200 views.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}